Diseases, Conditions, Syndromes

Chlamydia vaccine shows promise in early trial

A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).

Medical research

Chlamydia's stealthy cloaking device identified

Chlamydia, the leading cause of sexually transmitted bacterial infections, evades detection and elimination inside human cells by use of a cloaking device. But Duke University researchers have grasped the hem of that invisibility ...

Diseases, Conditions, Syndromes

Proteins discovered in gonorrhea may offer new approach to treatment

Researchers at Oregon State University have discovered novel proteins in, or on the surface of the bacteria that causes gonorrhea, which offer a promising new avenue of attack against a venereal disease that is showing increased ...

page 1 from 7